OCULAR THERAPEUTIX, INC - COM (OCUL)

Historical Portfolio Holders from Q3 2014 to Q3 2024

All holders as of June 30, 2024
Q2 2024
Type / Class
Equity / COM
Shares, excl. options Q2 2024
137M
Holdings value Q2 2024
$938M
Value change Q2 2024
+$86.7M
Grand Portfolio weight change Q2 2024
+0%
Number of holders
146
Number of buys Q2 2024
89
Number of sells Q2 2024
-61
Average buys Q2 2024 %
+0.002%
Average sells Q2 2024 %
-0.001%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 45.9K $400K +$393K $8.70 2
2024 Q2 137M $938M +$86.7M $6.84 146
2024 Q1 123M $1.12B +$454M $9.10 144
2023 Q4 73.5M $328M +$150M $4.46 117
2023 Q3 40.3M $126M -$14.5M $3.14 111
2023 Q2 43.3M $223M +$15.4M $5.16 132
2023 Q1 40.1M $212M +$6.22M $5.27 124
2022 Q4 39.4M $111M -$12M $2.81 108
2022 Q3 42.7M $177M -$6.25M $4.15 124
2022 Q2 44.2M $178M +$2.78M $4.02 120
2022 Q1 43.4M $215M +$8.62M $4.95 126
2021 Q4 41.4M $288M -$35.8M $6.97 136
2021 Q3 44.4M $444M -$46.1M $10.00 136
2021 Q2 48.2M $684M +$13.5M $14.18 144
2021 Q1 47.1M $773M -$66M $16.41 148
2020 Q4 50.4M $1.04B +$206M $20.70 147
2020 Q3 39.8M $303M +$7.27M $7.61 101
2020 Q2 38.7M $322M +$85.3M $8.33 104
2020 Q1 28.5M $141M +$17.9M $4.95 88
2019 Q4 25.2M $99.5M +$4.79M $3.95 77
2019 Q3 23.3M $70.8M +$1.14M $3.04 73
2019 Q2 22.7M $99.9M +$3.09M $4.40 67
2019 Q1 22.3M $88.6M +$2.35M $3.97 66
2018 Q4 21.5M $85.5M -$3.74M $3.98 66
2018 Q3 21.6M $149M -$1.2M $6.88 72
2018 Q2 22M $149M +$9.8M $6.75 69
2018 Q1 20.4M $133M +$45.6M $6.51 65
2017 Q4 13.5M $60.1M -$11.8M $4.45 67
2017 Q3 15.6M $96.5M -$1.1M $6.18 70
2017 Q2 15.5M $144M -$26.3M $9.27 72
2017 Q1 18.3M $170M +$20.3M $9.28 73
2016 Q4 17.4M $146M -$10M $8.37 76
2016 Q3 18.8M $129M -$2.94M $6.87 71
2016 Q2 19.5M $96.4M -$30.4M $4.95 74
2016 Q1 20.9M $201M -$1.63M $9.66 64
2015 Q4 21M $196M -$18.1M $9.37 70
2015 Q3 20M $282M +$50.3M $14.06 67
2015 Q2 16.1M $339M +$93.2M $21.03 71
2015 Q1 10.7M $449M +$241M $41.98 56
2014 Q4 5.01M $118M +$9.26M $23.52 36
2014 Q3 4.63M $69.3M +$69.3M $14.97 33